Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Tv Annuloplasty

Research Leaders

5 sponsors active, led by German Society for Thoracic and Cardiovascular Surgery

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT02675244Not ApplicableCompletedPrimary

Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery

Showing all 1 trials

Research Network

Common Treatments

  • Tv Annuloplasty1
  • Mvs1

Active Sponsors

  • German Society for Thoracic and Cardiovascular Surgery1
  • Canadian Institutes of Health Research (CIHR)1
  • Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)1
  • Icahn School of Medicine at Mount Sinai1
  • National Heart, Lung, and Blood Institute (NHLBI)1

Top Investigators

Related Conditions

  • Tricuspid Regurgitation1
  • Moderate Tricuspid Regurgitation1

Activity Timeline